JP2025501967A5 - - Google Patents
Info
- Publication number
- JP2025501967A5 JP2025501967A5 JP2024539654A JP2024539654A JP2025501967A5 JP 2025501967 A5 JP2025501967 A5 JP 2025501967A5 JP 2024539654 A JP2024539654 A JP 2024539654A JP 2024539654 A JP2024539654 A JP 2024539654A JP 2025501967 A5 JP2025501967 A5 JP 2025501967A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- salt
- formula
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111638123.4 | 2021-12-29 | ||
| CN202111638123 | 2021-12-29 | ||
| CN202210651178.7 | 2022-06-09 | ||
| CN202210651178 | 2022-06-09 | ||
| PCT/CN2022/143074 WO2023125738A1 (zh) | 2021-12-29 | 2022-12-29 | 用于递送的脂质和组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501967A JP2025501967A (ja) | 2025-01-24 |
| JP2025501967A5 true JP2025501967A5 (enExample) | 2026-01-14 |
Family
ID=86998079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539654A Pending JP2025501967A (ja) | 2021-12-29 | 2022-12-29 | 送達のための脂質及び組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250064750A1 (enExample) |
| EP (1) | EP4458806A4 (enExample) |
| JP (1) | JP2025501967A (enExample) |
| KR (1) | KR20240128984A (enExample) |
| CN (1) | CN120476106A (enExample) |
| AU (1) | AU2022424144A1 (enExample) |
| CA (1) | CA3242974A1 (enExample) |
| MX (1) | MX2024007242A (enExample) |
| TW (1) | TW202330458A (enExample) |
| WO (1) | WO2023125738A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023343844A1 (en) * | 2022-09-19 | 2025-04-10 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Method for preparing 2-hydroxyethyl aminocaproate compound and use thereof |
| AU2024307171A1 (en) | 2023-06-28 | 2026-01-15 | Shanghai Regenelead Therapies Co., Ltd. | Pharmaceutical composition containing cationic lipid and use thereof |
| WO2025103396A1 (zh) * | 2023-11-14 | 2025-05-22 | 上海瑞宏迪医药有限公司 | 一种含核酸构建体的药物组合物及其医药用途 |
| WO2025103414A1 (zh) * | 2023-11-14 | 2025-05-22 | 上海瑞宏迪医药有限公司 | 一种脂质纳米粒的制备方法和应用 |
| TW202532053A (zh) * | 2023-12-13 | 2025-08-16 | 大陸商上海瑞宏迪醫藥有限公司 | 用於遞送治療劑的組成物和化合物 |
| CN119019272A (zh) * | 2024-08-14 | 2024-11-26 | 中国药科大学 | 可电离脂质、包含其的组合物及其用途 |
| CN119191996A (zh) * | 2024-11-28 | 2024-12-27 | 浙江省质量科学研究院 | 一种双羟乙基氨基丙基羟乙基油胺的合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS63030B1 (sr) | 2015-09-17 | 2022-04-29 | Modernatx Inc | Jedinjenja i kompozicije za intracelularno isporučivanje terapeutskih sredstava |
| RS63986B1 (sr) * | 2015-10-28 | 2023-03-31 | Acuitas Therapeutics Inc | Novi lipidi i lipidne formulacije nanočestica za isporuku nukleinskih kiselina |
| BR112021021313A2 (pt) | 2019-04-25 | 2022-01-18 | Intellia Therapeutics Inc | Lipídios de amina ionizáveis e nanopartículas de lipídio |
| CN114763324A (zh) * | 2021-01-15 | 2022-07-19 | 纳肽得(青岛)生物医药有限公司 | 一种脂质化合物及脂质体与药物组合物 |
| CN113264842B (zh) * | 2021-07-21 | 2022-03-01 | 苏州科锐迈德生物医药科技有限公司 | 一种脂质化合物及包含其的脂质载体、核酸脂质纳米粒组合物和药物制剂 |
| CN114773217B (zh) * | 2022-06-20 | 2022-10-18 | 深圳市瑞吉生物科技有限公司 | 用于递送核酸的阳离子脂质化合物和组合物及用途 |
-
2022
- 2022-12-29 AU AU2022424144A patent/AU2022424144A1/en active Pending
- 2022-12-29 TW TW111150722A patent/TW202330458A/zh unknown
- 2022-12-29 CN CN202280076308.7A patent/CN120476106A/zh active Pending
- 2022-12-29 WO PCT/CN2022/143074 patent/WO2023125738A1/zh not_active Ceased
- 2022-12-29 CA CA3242974A patent/CA3242974A1/en active Pending
- 2022-12-29 KR KR1020247025244A patent/KR20240128984A/ko active Pending
- 2022-12-29 MX MX2024007242A patent/MX2024007242A/es unknown
- 2022-12-29 JP JP2024539654A patent/JP2025501967A/ja active Pending
- 2022-12-29 US US18/725,552 patent/US20250064750A1/en active Pending
- 2022-12-29 EP EP22914988.5A patent/EP4458806A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010509373A5 (enExample) | ||
| JP2022529370A5 (enExample) | ||
| AU2023201644B2 (en) | Lipid nanoparticles | |
| JP2020531418A5 (enExample) | ||
| WO2017222016A1 (ja) | カチオン性脂質 | |
| HRP20220268T1 (hr) | Spojevi i pripravci za unutarstaničnu isporuku sredstava | |
| EP4269385A1 (en) | Ionizable lipid compounds | |
| JP2023549226A5 (enExample) | ||
| JP2018514544A5 (enExample) | ||
| TW202106304A (zh) | 盧梭利替尼之緩釋性劑型 | |
| CA2893959A1 (en) | Pharmaceutical compositions | |
| EP3075739A1 (en) | A pentacyclic triterpenoid compound with modified structure and preparation method and use thereof | |
| JP2007522162A5 (enExample) | ||
| EP4729509A1 (en) | Ionizable lipid for muscle-specific delivery | |
| KR20250039418A (ko) | 아미노 지질 화합물, 그의 제조 방법 및 그의 용도 | |
| CA2631581A1 (en) | Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity | |
| CN120359199A (zh) | 新型化合物及其靶向递送用途 | |
| JP2022537964A5 (enExample) | ||
| CN115337267A (zh) | 一种基于脂质体纳米囊泡的酸响应型药物递送平台的制备方法及其应用 | |
| JP2024533182A5 (enExample) | ||
| JP2024536718A5 (enExample) | ||
| CA2883791A1 (en) | Bolaamphiphilic compounds, compositions and uses thereof | |
| CA3114462A1 (en) | Quinone reductase 2 inhibitor compounds and uses thereof | |
| AU2023203043B2 (en) | Lipid-based topical injection formulations | |
| CN118234713A (zh) | 用于递送核酸区段的新颖脂质 |